• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在药物发现和开发之间架起溶解度的桥梁。

Bridging solubility between drug discovery and development.

机构信息

Pharmacokinetics Dynamics and Metabolism, Pfizer Inc., Eastern Point Road, Groton, CT 06340, USA.

出版信息

Drug Discov Today. 2012 May;17(9-10):486-95. doi: 10.1016/j.drudis.2011.11.007. Epub 2011 Nov 26.

DOI:10.1016/j.drudis.2011.11.007
PMID:22138563
Abstract

Solubility has a crucial role in the success of a drug candidate. Compounds with low solubility not only cause problems for in vitro and in vivo assays, but also add significant burdens to drug development. Drug discovery and drug development often have different solubility screening requirements and methodologies have been developed to meet the needs of these different stages.

摘要

溶解度在候选药物的成功中起着至关重要的作用。溶解度低的化合物不仅会给体外和体内检测带来问题,而且会给药物开发带来巨大的负担。药物发现和药物开发通常有不同的溶解度筛选要求,已经开发了一些方法来满足这些不同阶段的需求。

相似文献

1
Bridging solubility between drug discovery and development.在药物发现和开发之间架起溶解度的桥梁。
Drug Discov Today. 2012 May;17(9-10):486-95. doi: 10.1016/j.drudis.2011.11.007. Epub 2011 Nov 26.
2
Strategies at the interface of drug discovery and development: early optimization of the solid state phase and preclinical toxicology formulation for potential drug candidates.药物发现与开发交叉领域的策略:潜在候选药物的固态相早期优化及临床前毒理学制剂研究
J Med Chem. 2010 Aug 26;53(16):5897-905. doi: 10.1021/jm1002638.
3
Medium-throughput hydrate screening using the Crystal 16™.使用 Crystal 16™ 进行高通量水合物筛选。
Pharm Dev Technol. 2011 Apr;16(2):102-9. doi: 10.3109/10837450903499366. Epub 2010 Jan 20.
4
In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome.用于药物“可开发性”评估的药物吸收体外测试:构建体外临床前数据与临床结果之间的桥梁
Curr Opin Drug Discov Devel. 2004 Jan;7(1):75-85.
5
Solubility: it's not just for physical chemists.溶解度:它不仅仅关乎物理化学家。
Drug Discov Today. 2006 Nov;11(21-22):1012-8. doi: 10.1016/j.drudis.2006.09.002. Epub 2006 Sep 26.
6
Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity.在药物发现中注重实际:对溶解度和疏水性的现代观点。
Drug Discov Today. 2010 Aug;15(15-16):648-55. doi: 10.1016/j.drudis.2010.05.016. Epub 2010 Jun 4.
7
Use of (1)H NMR to facilitate solubility measurement for drug discovery compounds.利用氢核磁共振(¹H NMR)促进药物发现化合物的溶解度测定。
Int J Pharm. 2009 Mar 18;369(1-2):47-52. doi: 10.1016/j.ijpharm.2008.10.038. Epub 2008 Nov 27.
8
Improvement in aqueous solubility in small molecule drug discovery programs by disruption of molecular planarity and symmetry.通过破坏分子平面性和对称性来提高小分子药物发现项目中的水溶性。
J Med Chem. 2011 Mar 24;54(6):1539-54. doi: 10.1021/jm101356p. Epub 2011 Feb 23.
9
Overview of determination of biopharmaceutical properties for development candidate selection.用于开发候选药物筛选的生物制药特性测定概述。
Curr Protoc Pharmacol. 2013 Mar;Chapter 9:Unit9.17. doi: 10.1002/0471141755.ph0917s60.
10
High throughput microsomal stability assay for insoluble compounds.针对不溶性化合物的高通量微粒体稳定性测定
Int J Pharm. 2006 Jul 6;317(1):54-60. doi: 10.1016/j.ijpharm.2006.03.007. Epub 2006 Mar 17.

引用本文的文献

1
Solvent Redistribution Method To Determine Solubility and Aggregation: High Throughput, Accuracy, and Sustainability.用于测定溶解度和聚集的溶剂再分配方法:高通量、准确性和可持续性。
J Phys Chem B. 2025 Aug 28;129(34):8798-8805. doi: 10.1021/acs.jpcb.5c03073. Epub 2025 Aug 19.
2
Machine learning analysis of molecular dynamics properties influencing drug solubility.影响药物溶解度的分子动力学性质的机器学习分析
Sci Rep. 2025 Jul 24;15(1):26955. doi: 10.1038/s41598-025-11392-1.
3
Effects of hydrostatic compression and kinetic vitrification on structural relaxation behaviors of amorphous drugs: how to predict them simple theoretical models?
静水压压缩和动态玻璃化对无定形药物结构松弛行为的影响:如何用简单理论模型预测它们?
RSC Adv. 2025 Jul 18;15(31):25675-25693. doi: 10.1039/d5ra03931b. eCollection 2025 Jul 15.
4
Ternary Solid Dispersions as an Alternative Approach to Enhance Pharmacological Activity.三元固体分散体作为增强药理活性的替代方法。
Drug Des Devel Ther. 2025 Jul 3;19:5663-5684. doi: 10.2147/DDDT.S533359. eCollection 2025.
5
Pyrroloquinolone-Based Compounds as a Novel Antimycobacterial Chemotype.基于吡咯并喹诺酮的化合物作为一种新型抗分枝杆菌化学类型
ACS Med Chem Lett. 2025 Jun 3;16(6):1139-1146. doi: 10.1021/acsmedchemlett.5c00183. eCollection 2025 Jun 12.
6
Preclinical pharmacokinetics and in vitro ADME properties of PAT-1102: a novel HDAC inhibitor for cancer therapy.PAT-1102的临床前药代动力学及体外吸收、分布、代谢和排泄特性:一种用于癌症治疗的新型组蛋白去乙酰化酶抑制剂
J Cancer Res Clin Oncol. 2025 May 24;151(5):174. doi: 10.1007/s00432-025-06227-5.
7
Prodrug Approach as a Strategy to Enhance Drug Permeability.前药策略作为增强药物渗透性的一种方法。
Pharmaceuticals (Basel). 2025 Feb 21;18(3):297. doi: 10.3390/ph18030297.
8
Temperature-dependent solubilization and thermodynamic characteristics of ribociclib in varied {PEG 400 + water} combinations.瑞博西尼在不同的{聚乙二醇400 + 水}组合中的温度依赖性增溶作用及热力学特征
BMC Chem. 2025 Mar 26;19(1):79. doi: 10.1186/s13065-025-01461-x.
9
Structure-activity relationship studies and design of a PTPN22 inhibitor with enhanced isozyme selectivity and cellular efficacy.具有增强的同工酶选择性和细胞功效的PTPN22抑制剂的构效关系研究与设计
Eur J Med Chem. 2025 Feb 5;283:117129. doi: 10.1016/j.ejmech.2024.117129. Epub 2024 Dec 6.
10
Novel -phenyl-2-(aniline) benzamide hydrochloride salt development for colon cancer therapy.用于结肠癌治疗的新型苯基-2-(苯胺)苯甲酰胺盐酸盐的研发。
Front Pharmacol. 2024 Oct 30;15:1452904. doi: 10.3389/fphar.2024.1452904. eCollection 2024.